The	O
N	B:C0598695
-	I:C0598695
Methyl	I:C0598695
d-Aspartate	I:C0598695
Glutamate	I:C0598695
Receptor	I:C0598695
Antagonist	I:C0598695
Ketamine	O
Disrupts	O
the	O
Functional	O
State	O
of	O
the	O
Corticothalamic	O
Pathway	O
.	O

The	O
N	O
-	I:C0598695
Methyl	I:C0598695
d-Aspartate	I:C0598695
Glutamate	I:C0598695
Receptor	I:C0598695
Antagonist	I:C0598695
Ketamine	B:C0022614
Disrupts	O
the	O
Functional	O
State	O
of	O
the	O
Corticothalamic	O
Pathway	O
.	O

The	O
N	O
-	I:C0598695
Methyl	I:C0598695
d-Aspartate	I:C0598695
Glutamate	I:C0598695
Receptor	I:C0598695
Antagonist	I:C0598695
Ketamine	O
Disrupts	O
the	O
Functional	O
State	O
of	O
the	O
Corticothalamic	B:C1184631
Pathway	O
.	O

The	O
non-competitive	O
N	B:C0598695
-	I:C0598695
methyl	I:C0598695
d-aspartate	I:C0598695
glutamate	I:C0598695
receptor	I:C0598695
(	I:C0598695
NMDAR	I:C0598695
)	I:C0598695
antagonist	I:C0598695
ketamine	O
elicits	O
a	O
brain	O
state	O
resembling	O
high	O
-	I:C0332167
risk	I:C0332167
states	O
for	O
developing	O
psychosis	O
and	O
early	O
stages	O
of	O
schizophrenia	O
characterized	O
by	O
sensory	O
and	O
cognitive	O
deficits	I:C0009241
and	O
aberrant	O
ongoing	O
gamma	O
oscillations	I:C0678909
(	O
30	O
-	O
80	O
Hz	O
)	O
in	O
cortical	O
and	O
subcortical	O
structures	O
,	O
including	O
the	O
thalamus	O
.	O

The	O
non-competitive	O
N	O
-	I:C0598695
methyl	I:C0598695
d-aspartate	I:C0598695
glutamate	I:C0598695
receptor	I:C0598695
(	I:C0598695
NMDAR	I:C0598695
)	I:C0598695
antagonist	I:C0598695
ketamine	B:C0022614
elicits	O
a	O
brain	O
state	O
resembling	O
high	O
-	I:C0332167
risk	I:C0332167
states	O
for	O
developing	O
psychosis	O
and	O
early	O
stages	O
of	O
schizophrenia	O
characterized	O
by	O
sensory	O
and	O
cognitive	O
deficits	I:C0009241
and	O
aberrant	O
ongoing	O
gamma	O
oscillations	I:C0678909
(	O
30	O
-	O
80	O
Hz	O
)	O
in	O
cortical	O
and	O
subcortical	O
structures	O
,	O
including	O
the	O
thalamus	O
.	O

The	O
non-competitive	O
N	O
-	I:C0598695
methyl	I:C0598695
d-aspartate	I:C0598695
glutamate	I:C0598695
receptor	I:C0598695
(	I:C0598695
NMDAR	I:C0598695
)	I:C0598695
antagonist	I:C0598695
ketamine	O
elicits	O
a	O
brain	B:C0006104
state	O
resembling	O
high	O
-	I:C0332167
risk	I:C0332167
states	O
for	O
developing	O
psychosis	O
and	O
early	O
stages	O
of	O
schizophrenia	O
characterized	O
by	O
sensory	O
and	O
cognitive	O
deficits	I:C0009241
and	O
aberrant	O
ongoing	O
gamma	O
oscillations	I:C0678909
(	O
30	O
-	O
80	O
Hz	O
)	O
in	O
cortical	O
and	O
subcortical	O
structures	O
,	O
including	O
the	O
thalamus	O
.	O

The	O
non-competitive	O
N	O
-	I:C0598695
methyl	I:C0598695
d-aspartate	I:C0598695
glutamate	I:C0598695
receptor	I:C0598695
(	I:C0598695
NMDAR	I:C0598695
)	I:C0598695
antagonist	I:C0598695
ketamine	O
elicits	O
a	O
brain	O
state	O
resembling	O
high	B:C0332167
-	I:C0332167
risk	I:C0332167
states	O
for	O
developing	O
psychosis	O
and	O
early	O
stages	O
of	O
schizophrenia	O
characterized	O
by	O
sensory	O
and	O
cognitive	O
deficits	I:C0009241
and	O
aberrant	O
ongoing	O
gamma	O
oscillations	I:C0678909
(	O
30	O
-	O
80	O
Hz	O
)	O
in	O
cortical	O
and	O
subcortical	O
structures	O
,	O
including	O
the	O
thalamus	O
.	O

The	O
non-competitive	O
N	O
-	I:C0598695
methyl	I:C0598695
d-aspartate	I:C0598695
glutamate	I:C0598695
receptor	I:C0598695
(	I:C0598695
NMDAR	I:C0598695
)	I:C0598695
antagonist	I:C0598695
ketamine	O
elicits	O
a	O
brain	O
state	O
resembling	O
high	O
-	I:C0332167
risk	I:C0332167
states	O
for	O
developing	O
psychosis	B:C0033975
and	O
early	O
stages	O
of	O
schizophrenia	O
characterized	O
by	O
sensory	O
and	O
cognitive	O
deficits	I:C0009241
and	O
aberrant	O
ongoing	O
gamma	O
oscillations	I:C0678909
(	O
30	O
-	O
80	O
Hz	O
)	O
in	O
cortical	O
and	O
subcortical	O
structures	O
,	O
including	O
the	O
thalamus	O
.	O

The	O
non-competitive	O
N	O
-	I:C0598695
methyl	I:C0598695
d-aspartate	I:C0598695
glutamate	I:C0598695
receptor	I:C0598695
(	I:C0598695
NMDAR	I:C0598695
)	I:C0598695
antagonist	I:C0598695
ketamine	O
elicits	O
a	O
brain	O
state	O
resembling	O
high	O
-	I:C0332167
risk	I:C0332167
states	O
for	O
developing	O
psychosis	O
and	O
early	O
stages	O
of	O
schizophrenia	B:C0036341
characterized	O
by	O
sensory	O
and	O
cognitive	O
deficits	I:C0009241
and	O
aberrant	O
ongoing	O
gamma	O
oscillations	I:C0678909
(	O
30	O
-	O
80	O
Hz	O
)	O
in	O
cortical	O
and	O
subcortical	O
structures	O
,	O
including	O
the	O
thalamus	O
.	O

The	O
non-competitive	O
N	O
-	I:C0598695
methyl	I:C0598695
d-aspartate	I:C0598695
glutamate	I:C0598695
receptor	I:C0598695
(	I:C0598695
NMDAR	I:C0598695
)	I:C0598695
antagonist	I:C0598695
ketamine	O
elicits	O
a	O
brain	O
state	O
resembling	O
high	O
-	I:C0332167
risk	I:C0332167
states	O
for	O
developing	O
psychosis	O
and	O
early	O
stages	O
of	O
schizophrenia	O
characterized	O
by	O
sensory	B:C0748618
and	O
cognitive	O
deficits	I:C0009241
and	O
aberrant	O
ongoing	O
gamma	O
oscillations	I:C0678909
(	O
30	O
-	O
80	O
Hz	O
)	O
in	O
cortical	O
and	O
subcortical	O
structures	O
,	O
including	O
the	O
thalamus	O
.	O

The	O
non-competitive	O
N	O
-	I:C0598695
methyl	I:C0598695
d-aspartate	I:C0598695
glutamate	I:C0598695
receptor	I:C0598695
(	I:C0598695
NMDAR	I:C0598695
)	I:C0598695
antagonist	I:C0598695
ketamine	O
elicits	O
a	O
brain	O
state	O
resembling	O
high	O
-	I:C0332167
risk	I:C0332167
states	O
for	O
developing	O
psychosis	O
and	O
early	O
stages	O
of	O
schizophrenia	O
characterized	O
by	O
sensory	O
and	O
cognitive	B:C0009241
deficits	I:C0009241
and	O
aberrant	O
ongoing	O
gamma	O
oscillations	I:C0678909
(	O
30	O
-	O
80	O
Hz	O
)	O
in	O
cortical	O
and	O
subcortical	O
structures	O
,	O
including	O
the	O
thalamus	O
.	O

The	O
non-competitive	O
N	O
-	I:C0598695
methyl	I:C0598695
d-aspartate	I:C0598695
glutamate	I:C0598695
receptor	I:C0598695
(	I:C0598695
NMDAR	I:C0598695
)	I:C0598695
antagonist	I:C0598695
ketamine	O
elicits	O
a	O
brain	O
state	O
resembling	O
high	O
-	I:C0332167
risk	I:C0332167
states	O
for	O
developing	O
psychosis	O
and	O
early	O
stages	O
of	O
schizophrenia	O
characterized	O
by	O
sensory	O
and	O
cognitive	O
deficits	I:C0009241
and	O
aberrant	O
ongoing	O
gamma	B:C0678909
oscillations	I:C0678909
(	O
30	O
-	O
80	O
Hz	O
)	O
in	O
cortical	O
and	O
subcortical	O
structures	O
,	O
including	O
the	O
thalamus	O
.	O

The	O
non-competitive	O
N	O
-	I:C0598695
methyl	I:C0598695
d-aspartate	I:C0598695
glutamate	I:C0598695
receptor	I:C0598695
(	I:C0598695
NMDAR	I:C0598695
)	I:C0598695
antagonist	I:C0598695
ketamine	O
elicits	O
a	O
brain	O
state	O
resembling	O
high	O
-	I:C0332167
risk	I:C0332167
states	O
for	O
developing	O
psychosis	O
and	O
early	O
stages	O
of	O
schizophrenia	O
characterized	O
by	O
sensory	O
and	O
cognitive	O
deficits	I:C0009241
and	O
aberrant	O
ongoing	O
gamma	O
oscillations	I:C0678909
(	O
30	O
-	O
80	O
Hz	O
)	O
in	O
cortical	B:C0007776
and	O
subcortical	O
structures	O
,	O
including	O
the	O
thalamus	O
.	O

The	O
non-competitive	O
N	O
-	I:C0598695
methyl	I:C0598695
d-aspartate	I:C0598695
glutamate	I:C0598695
receptor	I:C0598695
(	I:C0598695
NMDAR	I:C0598695
)	I:C0598695
antagonist	I:C0598695
ketamine	O
elicits	O
a	O
brain	O
state	O
resembling	O
high	O
-	I:C0332167
risk	I:C0332167
states	O
for	O
developing	O
psychosis	O
and	O
early	O
stages	O
of	O
schizophrenia	O
characterized	O
by	O
sensory	O
and	O
cognitive	O
deficits	I:C0009241
and	O
aberrant	O
ongoing	O
gamma	O
oscillations	I:C0678909
(	O
30	O
-	O
80	O
Hz	O
)	O
in	O
cortical	O
and	O
subcortical	O
structures	B:C0678594
,	O
including	O
the	O
thalamus	O
.	O

The	O
non-competitive	O
N	O
-	I:C0598695
methyl	I:C0598695
d-aspartate	I:C0598695
glutamate	I:C0598695
receptor	I:C0598695
(	I:C0598695
NMDAR	I:C0598695
)	I:C0598695
antagonist	I:C0598695
ketamine	O
elicits	O
a	O
brain	O
state	O
resembling	O
high	O
-	I:C0332167
risk	I:C0332167
states	O
for	O
developing	O
psychosis	O
and	O
early	O
stages	O
of	O
schizophrenia	O
characterized	O
by	O
sensory	O
and	O
cognitive	O
deficits	I:C0009241
and	O
aberrant	O
ongoing	O
gamma	O
oscillations	I:C0678909
(	O
30	O
-	O
80	O
Hz	O
)	O
in	O
cortical	O
and	O
subcortical	O
structures	O
,	O
including	O
the	O
thalamus	B:C0039729
.	O

The	O
goal	B:C0018017
of	O
the	O
present	O
study	O
was	O
to	O
determine	O
whether	O
a	O
ketamine	O
-	O
induced	O
psychotic	O
-	O
relevant	O
state	O
disturbs	O
the	O
functional	O
state	O
of	O
the	O
corticothalamic	O
(	O
corticothalamic	O
)	O
pathway	O
.	O

The	O
goal	O
of	O
the	O
present	O
study	B:C2603343
was	O
to	O
determine	O
whether	O
a	O
ketamine	O
-	O
induced	O
psychotic	O
-	O
relevant	O
state	O
disturbs	O
the	O
functional	O
state	O
of	O
the	O
corticothalamic	O
(	O
corticothalamic	O
)	O
pathway	O
.	O

The	O
goal	O
of	O
the	O
present	O
study	O
was	O
to	O
determine	O
whether	O
a	O
ketamine	B:C0022614
-	O
induced	O
psychotic	O
-	O
relevant	O
state	O
disturbs	O
the	O
functional	O
state	O
of	O
the	O
corticothalamic	O
(	O
corticothalamic	O
)	O
pathway	O
.	O

The	O
goal	O
of	O
the	O
present	O
study	O
was	O
to	O
determine	O
whether	O
a	O
ketamine	O
-	O
induced	O
psychotic	B:C0033975
-	O
relevant	O
state	O
disturbs	O
the	O
functional	O
state	O
of	O
the	O
corticothalamic	O
(	O
corticothalamic	O
)	O
pathway	O
.	O

The	O
goal	O
of	O
the	O
present	O
study	O
was	O
to	O
determine	O
whether	O
a	O
ketamine	O
-	O
induced	O
psychotic	O
-	O
relevant	O
state	O
disturbs	O
the	O
functional	O
state	O
of	O
the	O
corticothalamic	B:C1184631
(	O
corticothalamic	O
)	O
pathway	O
.	O

The	O
goal	O
of	O
the	O
present	O
study	O
was	O
to	O
determine	O
whether	O
a	O
ketamine	O
-	O
induced	O
psychotic	O
-	O
relevant	O
state	O
disturbs	O
the	O
functional	O
state	O
of	O
the	O
corticothalamic	O
(	O
corticothalamic	B:C1184631
)	O
pathway	O
.	O

Multisite	B:C0430022
field	I:C0430022
recordings	I:C0430022
were	O
performed	O
in	O
the	O
somatosensory	O
CT	O
system	O
of	O
the	O
sedated	O
rat	O
.	O

Multisite	O
field	I:C0430022
recordings	I:C0430022
were	O
performed	O
in	O
the	O
somatosensory	O
CT	O
system	O
of	O
the	O
sedated	B:C0235195
rat	O
.	O

Multisite	O
field	I:C0430022
recordings	I:C0430022
were	O
performed	O
in	O
the	O
somatosensory	O
CT	O
system	O
of	O
the	O
sedated	O
rat	B:C0034721
.	O

Baseline	O
activity	O
was	O
challenged	O
by	O
activation	O
of	O
vibrissa	B:C0042640
-	O
related	O
prethalamic	O
inputs	O
.	O

Baseline	O
activity	O
was	O
challenged	O
by	O
activation	O
of	O
vibrissa	O
-	O
related	O
prethalamic	B:C0152349
inputs	O
.	O

The	O
sensory	O
-	O
evoked	B:C0015214
thalamic	I:C0015214
response	I:C0015214
was	O
characterized	O
by	O
a	O
short	O
-	O
latency	O
(	O
∼4	O
ms	O
)	O
prethalamic	O
-	O
mediated	O
negative	O
sharp	O
potential	O
and	O
a	O
longer	O
latency	O
(	O
∼10	O
ms	O
)	O
corticothalamic	O
-	O
mediated	O
negative	O
potential	O
.	O

The	O
sensory	O
-	O
evoked	O
thalamic	I:C0015214
response	I:C0015214
was	O
characterized	O
by	O
a	O
short	O
-	O
latency	O
(	O
∼4	O
ms	O
)	O
prethalamic	B:C0152349
-	O
mediated	O
negative	O
sharp	O
potential	O
and	O
a	O
longer	O
latency	O
(	O
∼10	O
ms	O
)	O
corticothalamic	O
-	O
mediated	O
negative	O
potential	O
.	O

The	O
sensory	O
-	O
evoked	O
thalamic	I:C0015214
response	I:C0015214
was	O
characterized	O
by	O
a	O
short	O
-	O
latency	O
(	O
∼4	O
ms	O
)	O
prethalamic	O
-	O
mediated	O
negative	O
sharp	O
potential	B:C0001272
and	O
a	O
longer	O
latency	O
(	O
∼10	O
ms	O
)	O
corticothalamic	O
-	O
mediated	O
negative	O
potential	O
.	O

The	O
sensory	O
-	O
evoked	O
thalamic	I:C0015214
response	I:C0015214
was	O
characterized	O
by	O
a	O
short	O
-	O
latency	O
(	O
∼4	O
ms	O
)	O
prethalamic	O
-	O
mediated	O
negative	O
sharp	O
potential	O
and	O
a	O
longer	O
latency	O
(	O
∼10	O
ms	O
)	O
corticothalamic	B:C1184631
-	O
mediated	O
negative	O
potential	O
.	O

The	O
sensory	O
-	O
evoked	O
thalamic	I:C0015214
response	I:C0015214
was	O
characterized	O
by	O
a	O
short	O
-	O
latency	O
(	O
∼4	O
ms	O
)	O
prethalamic	O
-	O
mediated	O
negative	O
sharp	O
potential	O
and	O
a	O
longer	O
latency	O
(	O
∼10	O
ms	O
)	O
corticothalamic	O
-	O
mediated	O
negative	O
potential	B:C0001272
.	O

Following	O
a	O
single	O
subcutaneous	O
injection	O
of	O
ketamine	B:C0022614
(	O
2.5	O
mg/kg	O
)	O
,	O
spontaneously	O
occurring	O
and	O
sensory	O
-	O
evoked	O
thalamic	I:C0015214
gamma	I:C0015214
oscillations	I:C0015214
increased	O
and	O
decreased	O
in	O
power	O
,	O
respectively	O
.	O

Following	O
a	O
single	O
subcutaneous	O
injection	O
of	O
ketamine	O
(	O
2.5	O
mg/kg	O
)	O
,	O
spontaneously	O
occurring	O
and	O
sensory	O
-	O
evoked	B:C0015214
thalamic	I:C0015214
gamma	I:C0015214
oscillations	I:C0015214
increased	O
and	O
decreased	O
in	O
power	O
,	O
respectively	O
.	O

The	O
power	O
of	O
the	O
sensory	O
-	O
related	O
gamma	B:C0678909
oscillations	I:C0678909
was	O
positively	O
correlated	O
with	O
both	O
the	O
amplitude	O
and	O
the	O
area	O
under	O
the	O
curve	O
of	O
the	O
corresponding	O
corticothalamic	O
potential	O
but	O
not	O
with	O
the	O
prethalamic	O
potential	O
.	O

The	O
power	O
of	O
the	O
sensory	O
-	O
related	O
gamma	O
oscillations	I:C0678909
was	O
positively	B:C1446409
correlated	O
with	O
both	O
the	O
amplitude	O
and	O
the	O
area	O
under	O
the	O
curve	O
of	O
the	O
corresponding	O
corticothalamic	O
potential	O
but	O
not	O
with	O
the	O
prethalamic	O
potential	O
.	O

The	O
power	O
of	O
the	O
sensory	O
-	O
related	O
gamma	O
oscillations	I:C0678909
was	O
positively	O
correlated	O
with	O
both	O
the	O
amplitude	B:C2346753
and	O
the	O
area	O
under	O
the	O
curve	O
of	O
the	O
corresponding	O
corticothalamic	O
potential	O
but	O
not	O
with	O
the	O
prethalamic	O
potential	O
.	O

The	O
power	O
of	O
the	O
sensory	O
-	O
related	O
gamma	O
oscillations	I:C0678909
was	O
positively	O
correlated	O
with	O
both	O
the	O
amplitude	O
and	O
the	O
area	O
under	O
the	O
curve	O
of	O
the	O
corresponding	O
corticothalamic	B:C1184631
potential	O
but	O
not	O
with	O
the	O
prethalamic	O
potential	O
.	O

The	O
power	O
of	O
the	O
sensory	O
-	O
related	O
gamma	O
oscillations	I:C0678909
was	O
positively	O
correlated	O
with	O
both	O
the	O
amplitude	O
and	O
the	O
area	O
under	O
the	O
curve	O
of	O
the	O
corresponding	O
corticothalamic	O
potential	B:C0001272
but	O
not	O
with	O
the	O
prethalamic	O
potential	O
.	O

The	O
power	O
of	O
the	O
sensory	O
-	O
related	O
gamma	O
oscillations	I:C0678909
was	O
positively	O
correlated	O
with	O
both	O
the	O
amplitude	O
and	O
the	O
area	O
under	O
the	O
curve	O
of	O
the	O
corresponding	O
corticothalamic	O
potential	O
but	O
not	O
with	O
the	O
prethalamic	B:C0152349
potential	O
.	O

The	O
power	O
of	O
the	O
sensory	O
-	O
related	O
gamma	O
oscillations	I:C0678909
was	O
positively	O
correlated	O
with	O
both	O
the	O
amplitude	O
and	O
the	O
area	O
under	O
the	O
curve	O
of	O
the	O
corresponding	O
corticothalamic	O
potential	O
but	O
not	O
with	O
the	O
prethalamic	O
potential	B:C0001272
.	O

The	O
present	O
results	O
show	O
that	O
the	O
layer	B:C2322689
VI	I:C2322689
corticothalamic	O
pathway	O
significantly	O
contributes	O
in	O
thalamic	O
gamma	O
oscillations	I:C0678909
,	O
and	O
they	O
support	O
the	O
hypothesis	O
that	O
reduced	O
N	O
-	I:C0080093
methyl	I:C0080093
d-aspartate	I:C0080093
glutamate	I:C0080093
receptor	I:C0080093
activation	O
disturbs	O
the	O
functional	O
state	O
of	O
corticothalamic	O
and	O
corticocortical	O
networks	O
.	O

The	O
present	O
results	O
show	O
that	O
the	O
layer	O
VI	I:C2322689
corticothalamic	B:C1184631
pathway	O
significantly	O
contributes	O
in	O
thalamic	O
gamma	O
oscillations	I:C0678909
,	O
and	O
they	O
support	O
the	O
hypothesis	O
that	O
reduced	O
N	O
-	I:C0080093
methyl	I:C0080093
d-aspartate	I:C0080093
glutamate	I:C0080093
receptor	I:C0080093
activation	O
disturbs	O
the	O
functional	O
state	O
of	O
corticothalamic	O
and	O
corticocortical	O
networks	O
.	O

The	O
present	O
results	O
show	O
that	O
the	O
layer	O
VI	I:C2322689
corticothalamic	O
pathway	O
significantly	O
contributes	O
in	O
thalamic	B:C0039729
gamma	O
oscillations	I:C0678909
,	O
and	O
they	O
support	O
the	O
hypothesis	O
that	O
reduced	O
N	O
-	I:C0080093
methyl	I:C0080093
d-aspartate	I:C0080093
glutamate	I:C0080093
receptor	I:C0080093
activation	O
disturbs	O
the	O
functional	O
state	O
of	O
corticothalamic	O
and	O
corticocortical	O
networks	O
.	O

The	O
present	O
results	O
show	O
that	O
the	O
layer	O
VI	I:C2322689
corticothalamic	O
pathway	O
significantly	O
contributes	O
in	O
thalamic	O
gamma	B:C0678909
oscillations	I:C0678909
,	O
and	O
they	O
support	O
the	O
hypothesis	O
that	O
reduced	O
N	O
-	I:C0080093
methyl	I:C0080093
d-aspartate	I:C0080093
glutamate	I:C0080093
receptor	I:C0080093
activation	O
disturbs	O
the	O
functional	O
state	O
of	O
corticothalamic	O
and	O
corticocortical	O
networks	O
.	O

The	O
present	O
results	O
show	O
that	O
the	O
layer	O
VI	I:C2322689
corticothalamic	O
pathway	O
significantly	O
contributes	O
in	O
thalamic	O
gamma	O
oscillations	I:C0678909
,	O
and	O
they	O
support	O
the	O
hypothesis	O
that	O
reduced	O
N	B:C0080093
-	I:C0080093
methyl	I:C0080093
d-aspartate	I:C0080093
glutamate	I:C0080093
receptor	I:C0080093
activation	O
disturbs	O
the	O
functional	O
state	O
of	O
corticothalamic	O
and	O
corticocortical	O
networks	O
.	O

The	O
present	O
results	O
show	O
that	O
the	O
layer	O
VI	I:C2322689
corticothalamic	O
pathway	O
significantly	O
contributes	O
in	O
thalamic	O
gamma	O
oscillations	I:C0678909
,	O
and	O
they	O
support	O
the	O
hypothesis	O
that	O
reduced	O
N	O
-	I:C0080093
methyl	I:C0080093
d-aspartate	I:C0080093
glutamate	I:C0080093
receptor	I:C0080093
activation	B:C1514758
disturbs	O
the	O
functional	O
state	O
of	O
corticothalamic	O
and	O
corticocortical	O
networks	O
.	O

The	O
present	O
results	O
show	O
that	O
the	O
layer	O
VI	I:C2322689
corticothalamic	O
pathway	O
significantly	O
contributes	O
in	O
thalamic	O
gamma	O
oscillations	I:C0678909
,	O
and	O
they	O
support	O
the	O
hypothesis	O
that	O
reduced	O
N	O
-	I:C0080093
methyl	I:C0080093
d-aspartate	I:C0080093
glutamate	I:C0080093
receptor	I:C0080093
activation	O
disturbs	O
the	O
functional	O
state	O
of	O
corticothalamic	B:C1184631
and	O
corticocortical	O
networks	O
.	O

The	O
present	O
results	O
show	O
that	O
the	O
layer	O
VI	I:C2322689
corticothalamic	O
pathway	O
significantly	O
contributes	O
in	O
thalamic	O
gamma	O
oscillations	I:C0678909
,	O
and	O
they	O
support	O
the	O
hypothesis	O
that	O
reduced	O
N	O
-	I:C0080093
methyl	I:C0080093
d-aspartate	I:C0080093
glutamate	I:C0080093
receptor	I:C0080093
activation	O
disturbs	O
the	O
functional	O
state	O
of	O
corticothalamic	O
and	O
corticocortical	B:C0007776
networks	O
.	O

The	O
present	O
results	O
show	O
that	O
the	O
layer	O
VI	I:C2322689
corticothalamic	O
pathway	O
significantly	O
contributes	O
in	O
thalamic	O
gamma	O
oscillations	I:C0678909
,	O
and	O
they	O
support	O
the	O
hypothesis	O
that	O
reduced	O
N	O
-	I:C0080093
methyl	I:C0080093
d-aspartate	I:C0080093
glutamate	I:C0080093
receptor	I:C0080093
activation	O
disturbs	O
the	O
functional	O
state	O
of	O
corticothalamic	O
and	O
corticocortical	O
networks	B:C0598941
.	O

